Digestive Remedies in Egypt

Euromonitor International, November 2012, Pages: 27

The 2011 revolution had only a slight impact on sales of digestive remedies in the year. Growth slowed slightly in current value terms, dropping from a review period CAGR of 13% to 12%. However, growth rates remained strong, with this linked to ongoing strict price controls. While high inflation resulted in soaring prices for most fast-moving consumer goods in Egypt, price controls for medicines are not inflation-linked. Antacids and paediatric indigestion and heartburn remedies, the sole two...

Euromonitor International's Digestive Remedies in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Digestive Remedies market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

DIGESTIVE REMEDIES IN EGYPT
Euromonitor International
November 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Digestive Remedies by Category: Value 2006-2011
Table 2 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
Table 3 Digestive Remedies Company Shares by Value 2007-2011
Table 4 Digestive Remedies Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016
Amoun Pharmaceutical Industry Co in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 1 Amoun Pharmaceutical Industry Co: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Amoun Pharmaceutical Industry Co: Competitive Position 2011
Egyptian International Pharmaceutical Industries Co Sae (eipico) in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 3 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Key Facts
Summary 4 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Egyptian International Pharmaceutical Industries Co SAE (EIPICO): Competitive Position 2011
Pharco Pharmaceuticals in Consumer Health (egypt)
Strategic Direction
Key Facts
Summary 6 Pharco Pharmaceuticals: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 Pharco Pharmaceuticals: Competitive Position 2011
Executive Summary
Growth Boosted by Emergent Mid-income Group
Sales Hindered by Legislative Environment and Limited Distribution
Price Controls and 2011 Revolution Also Impact Growth
Domestic Players Continue To Lead
Health-awareness To Drive Growth in Forecast Period
Key Trends and Developments
Lack of Differentiation Between Otc, Rx and Utc Sales
Strong Competition From Herbal/traditional Products
Internet Retailing Offers An Alternative To Chemists/pharmacies
Revolution Has Little Impact on Sales Thanks To Emerging Mid-income Group
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Definitions
Sources
Summary 8 Research Sources

CH06drEG

Customers who bought this item also bought

• Consumer Health in Egypt
• Egypt Pharmaceuticals and Healthcare Report Q2 2013
• IMS Country Review: Egypt
• Digestive Remedies in Iran
• Egypt Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2018
• Egypt Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2017
• Digestive Remedies in Kenya
• Digestive Remedies in Nigeria
• Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
• Digestive Remedies in South Korea